Literature DB >> 29702478

Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design.

Béla Kovács1,2, Lajos Kristóf Kántor1, Mircea Dumitru Croitoru3, Éva Katalin Kelemen1, Mona Obreja1, Előd Ernő Nagy2, Blanka Székely-Szentmiklósi4, Árpád Gyéresi4.   

Abstract

A reverse-phase HPLC (RP-HPLC) method was developed for strontium ranelate using a full factorial, screening experimental design. The analytical procedure was validated according to international guidelines for linearity, selectivity, sensitivity, accuracy and precision. A separate experimental design was used to demonstrate the robustness of the method. Strontium ranelate was eluted at 4.4 minutes and showed no interference with the excipients used in the formulation, at 321 nm. The method is linear in the range of 20-320 μg mL-1 (R2 = 0.99998). Recovery, tested in the range of 40-120 μg mL-1, was found to be 96.1-102.1 %. Intra-day and intermediate precision RSDs ranged from 1.0-1.4 and 1.2-1.4 %, resp. The limit of detection and limit of quantitation were 0.06 and 0.20 μg mL-1, resp. The proposed technique is fast, cost-effective, reliable and reproducible, and is proposed for the routine analysis of strontium ranelate.

Entities:  

Keywords:  HPLC; experimental design; full factorial design; strontium ranelate

Mesh:

Substances:

Year:  2018        PMID: 29702478     DOI: 10.2478/acph-2018-0019

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  1 in total

1.  Development and Validation of an HPLC Method Using an Experimental Design for Analysis of Amlodipine Besylate and Enalapril Maleate in a Fixed-dose Combination

Authors:  Diren Sarısaltık Yaşın; Alev Arslantürk Bingül; Alptuğ Karaküçük; Zeynep Şafak Teksin
Journal:  Turk J Pharm Sci       Date:  2021-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.